By staying proactive and patient-centric, providers can help patients continue their weight-loss journey safely and effectively. Patients may feel frustrated, confused or anxious about losing access to medications that were working for them
Molecular Metabolism LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept Coskun T, Sloop KW, Loghin C, et al
When to Contact Your Provider Contact your healthcare provider immediately if you experience: Diarrhea lasting more than 3 days Daily diarrhea throughout the week (not just after injection) Signs of dehydration (dizziness, dry mouth, dark urine, confusion) Severe abdominal pain or cramping Blood or mucus in stool Fever above 101F (38.3C) Significant weight loss Unable to keep fluids down Quick Tips Diarrhea in the first 1-2 days after injection is normal for some patients Track bowel movements to identify patterns Stay near a bathroom if you experience post-injection diarrhea Use barrier cream if experiencing frequent bowel movements Most patients find diarrhea improves after dose stabilization Never ignore persistent diarrheadehydration is dangerous References Nauck MA, et al
All three programs operate nationwide and route prescriptions to a clinician licensed in your state of residence
The nano-semaglutide and microneedle claims made by Patched GLP-1 are marketing claims with no clinical proof
The verdict: speed goes to MEDVi by roughly 2 to 3 weeks, or 5 to 9 weeks if Ro pursues insurance
